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Abstract 
The colonization of poultry with different Salmonella enterica serovars poses an issue throughout the world. In this 
study we therefore tested the efficacy of a vaccine consisting of attenuated strains of Salmonella enterica serovars 
Enteritidis, Typhimurium and Infantis against challenge with the same serovars and with S. Agona, Dublin and Hadar. 
We tested oral and aerosol administration of the vaccine, with or without co‑administration of cecal microbiota from 
adult hens. The protective effect was determined by bacterial counts of the challenge strains up to week 18 of life 
and by characterizing the immune response using real‑time PCR specific for 16 different genes. We have shown that 
a vaccine consisting of attenuated S. Enteritidis, S. Typhimurium and S. Infantis protected chickens against challenge 
with the wild type strains of the same serovars and partially protected chickens also against challenge with isolates 
belonging to serovars Dublin or Hadar. Aerosol vaccination was more effective at inducing systemic immunity whilst 
oral vaccination stimulated a local immune response in the gut. Co‑administration of cecal microbiota increased the 
protectiveness in the intestinal tract but slightly decreased the systemic immune response. Adjusting the vaccine 
composition and changing the administration route therefore affects vaccine efficacy.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Although the incidence of human salmonellosis is gradu-
ally decreasing in the EU, Salmonella enterica is still one 
of the most frequent causative agents of gastroenteritis 
in humans worldwide [1]. Since the major reservoirs of 
Salmonella enterica for human populations are found in 
poultry flocks [2], it is expected that a decrease in Salmo-
nella prevalence in poultry will also result in a decrease 
in the incidence of human salmonellosis.
One of the most feasible ways of reducing Salmonella 
prevalence in poultry flocks is vaccination. However, cur-
rent live attenuated vaccines and vaccination schemes, 
though effective, exhibit several limitations. Live com-
mercial vaccines for poultry are available for S. enterica 
serovars Enteritidis, Typhimurium and Gallinarum only, 
whilst there are over 2600 serovars of Salmonella enterica 
able to cause disease [3] and contradicting data have been 
reported on the protection of chickens vaccinated and 
challenged with different serovars [4–7]. Another issue 
in poultry production is that live Salmonella vaccines 
are usually administered via drinking water and due to 
the logistics in commercial poultry production, chickens 
are vaccinated after being transported from hatcheries to 
farms, i.e. at the age of 2 or 3 days. There is therefore no 
protection during the first 48–72 h of life despite the fact 
that chickens are the most sensitive to Salmonella infec-
tion immediately after hatching [8], and an immediate 
vaccination after hatching could partially protect chick-
ens by growth inhibition of closely related Salmonella 
strains [9].
Rapid vaccination soon after hatching can be achieved 
by spraying. Although there are several reports on aero-
sol administration of live Salmonella vaccines to chickens 
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[10–12], there is no data on the long term protection 
following this mode of vaccine administration. Moreo-
ver, chickens vaccinated by aerosol in these studies were 
challenged orally and although oral challenge test the 
induction of gut immunity, it may not be sufficient for the 
characterization of systemic immunity. Finally, since mul-
tiple tissues are stimulated following aerosol vaccination 
(i.e. respiratory tract and conjunctiva), a less localized 
and more systemic immune response can be expected.
Specific immunity requires approx. 2 weeks to develop. 
Although a certain degree of protection can be achieved 
by mere Salmonella–Salmonella competition, such pro-
tective potential is usually decreased in attenuated vac-
cine strains [13]. Independent experiments showed that 
chickens can be protected against Salmonella infection 
by providing them with microbiota from adult hens [14, 
15], i.e. before the onset of specific immunity due to the 
vaccination. A combination of both approaches would 
result in immediate protection by microbiota followed by 
a specific immune response due to the vaccination. This 
has been tested successfully, although wild type S. Typh-
imurium, i.e. not an attenuated strain, was used for the 
immunization [16]. Moreover, with increasing knowledge 
of chicken microbiota composition and function [17, 18], 
the combination of vaccination and microbiota adminis-
tration may represent a field worth pursuing.
In this study we therefore constructed a vaccine con-
sisting of attenuated strains of three different serovars 
including S. Enteritidis, S. Typhimurium and S. Infantis. 
The vaccine was provided to chickens orally and by aero-
sol, with or without supplementation with gut microbiota 
and subsequently we tested and compared its protective 




S. Enteritidis  147, S. Typhimurium 16E5 and S. Infantis 
18G6 were used in this study. S. Enteritidis is a poultry 
isolate of phage type 4 with proven virulence for chick-
ens and mice [19, 20]. S. Typhimurium is an isolate of 
phage type DT104 but without the multidrug resistance 
genomic island SGI1 [21]. S. Infantis has been selected as 
representing the most frequent S. Infantis clone detected 
in our previous study [22]. Clones sensitive to all com-
monly used antibiotics were used for the generation of 
attenuated mutants though for the challenge we used the 
same strains selected as spontaneously resistant to nali-
dixic acid. S. Derby, S. Hadar and S. Agona originated 
from laboratory collection of different Salmonella iso-
lates resistant to antibiotics including nalidixic acid. All 
the strains were grown statically in LB broth or LB agar 
plates for 18 h at 37 °C.
The deletions in S. Enteritidis, Typhimurium and Infan-
tis were produced as follows. First, the whole Salmonella 
pathogenicity island 1 (SPI1) was replaced with a kana-
mycin resistance gene cassette by λ red recombination, 
as described previously [23]. In the case of S. Enteritidis 
and S. Typhimurium, SPI1::Kan mutation was transduced 
with P22 phage into a fresh wild type strain. Since P22 
does not propagate in S. Infantis, in this serovar we pro-
ceeded directly with the SPI1::Kan mutant generated 
by λ red recombination. This first step resulted in dele-
tion of SPI1 but also served as a transient introduction 
of kanamycin resistance which was used as the selection 
marker during further manipulations. The remaining 
deletions were generated using overlap PCR to construct 
sequences with deletions [24]. The PCR products were 
cloned into pDM4 plasmid [25] and the plasmid was 
transferred by conjugation into the appropriate Salmo-
nella strain, selecting for kanamycin (selection marker 
of SPI1::Kan mutants) and chloramphenicol (selection 
marker of pDM4) resistant clones, and selecting for 
chloramphenicol sensitive clones following growth of 
the recombinants in the presence of 5% sucrose [25]. In 
this way, lon, fliC and fljB (in the case of S. Typhimurium 
and S. Infantis) genes from start codon to stop codon 
were removed. Finally a “deleted” PCR product spanning 
SPI1::Kan sequence was generated, cloned into pDM4 
and conjugated into Salmonella strains. Final recom-
binants were then selected as sensitive both to chloram-
phenicol and kanamycin. All the deletions were verified 
by PCR and finally, genomic sequences of S. Enteritidis, 
S. Typhimurium, S. Infantis wild type strains and their 
deletion mutants (without gap closures) were determined 
using NextSeq sequencing to confirm the deletions and 
exclude any unexpected genomic rearrangements.
Experimental animals
Male, newly-hatched ISA Brown chickens (Hendrix 
Genetics, the Netherlands) were used in this study. The 
chickens were reared in perforated plastic boxes with 
free access to water and feed. Each of the experimental 
or control groups was kept in a separate room. All the 
experiments were approved by the Committee for Ani-
mal Welfare of the Ministry of Agriculture of the Czech 
Republic under permit number MZe1480.
Experimental design
In the first experiment we tested the protective effect 
against challenge with homologous serovars. Forty-two 
chickens were orally administered a mixture containing 
1  ×  106 CFU of attenuated S. Enteritidis, S. Typhimu-
rium and S. Infantis strains in 0.1  mL of inoculum on 
day 1 of life and an additional 36 chickens served as non-
vaccinated controls. On day 21, six vaccinated chickens 
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were sacrificed to check for residual colonization of the 
vaccine strains and the remaining chickens were divided 
into 6 groups of 12 birds each. The vaccinated chickens, 
as well as the non-vaccinated chickens, were challenged 
with 3 × 107 CFU of wild type S. Enteritidis, S. Typhimu-
rium or S. Infantis in 0.1  mL of inoculum, respectively. 
Six chickens from each group were humanely euthanized 
4 and 14 days post infection (dpi) and Salmonella counts 
in the cecum and liver were determined.
In the second experiment we tested protection against 
challenge with heterologous serovars S. Hadar, S. Agona 
and S. Dublin. The experiment was performed exactly as 
described above except that we included one more group 
which was challenged with S. Enteritidis to allow for a 
control with results from the previous “homologous chal-
lenge” experiment and on day 21, 12 vaccinated chickens 
were sacrificed to check for residual colonization of the 
vaccine strains.
Since in the initial vaccination experiments we observed 
that vaccine strains were present in the chickens on day 
21 prior to the challenge, in the next experiment we tested 
shedding of the vaccine strains. Six chickens were orally 
vaccinated with 1 × 106 CFU of the mixture of attenuated 
S. Enteritidis, S. Typhimurium and S. Infantis strains in 
0.1 mL of inoculum on day 1 of life and revaccinated on 
day 21. Cloacal swabs were taken from all these chickens 
in weekly intervals from week 6 to week 14 of life.
In the last experiment we addressed to what extent 
the mode of vaccine administration and formulation 
would affect long-term protection. The first group of 
chickens served as a non-vaccinated control. Chickens 
in the remaining three groups were vaccinated on the 
day 1 of life. Chickens in group 2 were orally vaccinated 
with a mixture of attenuated S. Enteritidis, S. Typhimu-
rium and S. Infantis. Group 3 was orally vaccinated with 
the vaccine strains mixed with an equal volume of cecal 
extract (referred to as cecal microbiota) from 34-week-old 
healthy hens. The cecal extract was prepared by pooling 
an equal amount of cecal contents of 3 donor hens and 
resuspension of 0.5 g of the cecal content in 5 mL of PBS 
with 1 mM cysteine. Following centrifugation at 500g for 
1 min, the supernatant was collected and mixed with an 
equal volume of vaccine strains. In the last group of chick-
ens, vaccine strains were administered by coarse aerosol 
application. The chickens were revaccinated orally on 
week 3 and 12 of life with the mixture of three vaccine 
strains and the revaccinations were performed in all vac-
cinated groups in the same way, i.e. irrespective of the first 
way of vaccine administration. When the chickens were 
6 and 18  weeks old, six chickens from each group were 
challenged with S. Enteritidis, three of them orally and the 
other three intravenously. All the chickens were sacrificed 
4 days later and S. Enteritidis counts were determined in 
the cecum and liver. In addition, three non-vaccinated 
and non-infected chickens were sacrificed.
Bacteriology
After necropsy, approximately 0.5  g of liver tissue and 
cecal contents were homogenized in peptone water and 
tenfold serial dilutions were plated on XLD agar plates 
(HiMedia) supplemented with 20  µg/mL nalidixic acid 
for Salmonella enumeration. Samples negative for Sal-
monella after direct plating were subjected to enrichment 
in modified semi-solid Rappaport-Vassiliadis medium 
(Oxoid) for qualitative Salmonella determination. Counts 
positive for Salmonella after direct plating were logarith-
mically transformed. Samples positive only after enrich-
ment were assigned a value of one and negative samples 
were assigned a value of zero.
RNA purification, reverse transcription and real‑time PCR
Liver and cecal tissue was collected into RNALater in 
the experiment with aerosol vaccination and stored 
at −80  °C. Total RNA was isolated with RNeasy Mini 
Kit (Qiagen), the concentration and purity of RNA was 
determined spectrophotometrically (Nanodrop, Thermo 
Scientific) and 1  µg of RNA was immediately reverse 
transcribed into cDNA using M-MLV reverse tran-
scriptase (Invitrogen) and oligo dT primers. After reverse 
transcription, the cDNA was diluted 10 times with sterile 
water and kept at −20 °C prior to real-time PCR.
Quantitative real-time RT-PCR (qRT-PCR) was used 
to determine gene expression. Gene expression in the 
cecum was determined for AH221, AVD, CSF3, ES1, EX-
FABP, IL-22, IL4I1, IL8, INFγ, iNOS, IRG1, LYG2, MMP7, 
MRP126, SAA and TRAP6 and gene expression in the 
liver was characterized by the expression of a slightly 
different subset comprising AVD, CSF3, EX-FABP, IgG, 
IL4I1, IRG1, MRP126, PTGDS, SAA, SCYA4, serpinB10, 
TGM4 and TRAP6. A list of all the primers together with 
a brief description of each gene function can be found 
in the Table  1 or recent review [26]. qRT-PCR was per-
formed in 3  μL volumes in 384-well microplates using 
QuantiTect SYBR Green PCR Master Mix (Qiagen) and 
a Nanodrop II Stage pipetting station (Innovadyne, Farn-
borough, UK) for PCR mix dispensing. The amplification 
of PCR products and signal detection were performed 
using a LightCycler II (Roche, Basel, Switzerland) with 
an initial denaturation at 95 °C for 15 min followed by 40 
cycles of 95 °C for 20 s, 60 °C for 30 s and 72 °C for 30 s. 
Each sample was subjected to qRT-PCR in duplicate and 
the mean Ct value of duplicates was used for subsequent 
calculations. The Ct values of the genes of interest were 
normalized (ΔCt) to an average Ct value of three house-
keeping genes (GAPDH, TBP and UB) and the relative 
expression of each gene of interest was calculated as 2−ΔCt.
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Statistical analysis
A t test was used for the comparison of Salmonella 
counts in the liver comparing the counts in the vacci-
nated and non-vaccinated chickens after the challenge 
with the same serovar. In the experiment with oral and 
aerosol vaccination, ANOVA followed by Tukey’s test 
was used. χ2 test was used for the comparison of Sal-
monella presence or absence in the ceca of vaccinated 
and non-vaccinated chickens. All calculations were per-
formed in Statistica v.9.1 software (StatSoft Inc., Tulsa, 
Table 1 List of primers used in this study
Gene Gene function Orient Primer 5′–3′
AH221 CC type chemokine For CTCTGCTCCTCGGCTGTG
Rev TCCTTCCCTTTCTTGGTCAC
AVD Avidin For CCTTTGGCTTCACTGTCAAT
Rev GCGAGTGAAGATGTTGATGC
CSF3 Colony stimulating factor 3 For AACCTCTCCTCCAACATCCAG
Rev GTACGCCGTCTCCAGGAAG
ES1 ES1 protein homolog, mitochondrial‑like For GGTGTACGATGGCAGTGAGAT
Rev CTCTGGCTATTCTGGCACTTTC
ExFABP Extracellular fatty acid binding protein For GGAACTACACGGATGAGATGGT
Rev TGGCACATTAGTCTTGCTTTGT
IgG IgG (IgY) immunoglobulin For GGGAGAAGAGTGGGAACCTC
Rev ATAACCAATCCTGGGTGCTG
IL22 Interleukin IL‑22 For CAGGAATCGCACCTACACCT
Rev TCATGTAGCAGCGGTTGTTC
IL4I IL4‑inducible gene For GGAGAAGGACTGGTATGTGGAG
Rev GCTTCAGGTCAAACTGCCTTAT
IL8 Interleukin IL‑8 For CAAGCCAAACACTCCTAACCAT
Rev AGCTCATTCCCCATCTTTACC
INFγ Interferon γ For GCC GCA CATCAAACACATATCT
Rev TGAGACTGGCTCCTTTTCCTT
iNOS Inducible NO synthase For GAACAGCCAGCTCATCCGATA
Rev CCCAAGCTCAATGCACAACTT
IRG1 Immune responsive gene 1 For TCGTCGAAATCCATTGAGTG
Rev ACCGAGGTCTGCCAGAAAGT
LYG2 Lysozyme G2 For GGGCACGAGAATACTTATTGACA
Rev TCATTGCTGTAGTCATCATGGAG
MMP7 Matrix metalloproteinase 7 For GATGATGCAATTAGAAGGGCTTT
Rev CCACCTCTTCCATCAAAAGGATA
MRP126 Protein MRP‑126 For TGAAGCTCTTGATTGAGAAGCA
Rev CGAGATCCTTGAAGATTTGGTC
PTGDS Prostaglandin D2 synthase For CATTCCTGTGCAAGCTGACTT
Rev CTGTTCCTCTTCTCGCACTGTT
SAA Serum amyloid A For GCTTCGTGTTGCTCTCCATT
Rev TAGTTTGCCTCACGCATGTC
SCYA4 Small inducible cytokine A4, MIP‑1β For TCATGCTGGTGTTGTGTTCA
Rev GGTGCATCAGTTCAGTTCCA
SERPINB10 Serine protease inhibitor For AGACTCAGGTCTTCTCTCTCACG
Rev TGTTGGTCTCATTCAGCTTGTT
TGM4 Transglutaminase 4 For GCCTTCAACATACACAGCAAAC
Rev CAGACATGGCTCTGGATACAAC
TRAP6 Trappin 6 For CACGGGGACACAGGCACCCTT
Rev CCACCCACCATCCCCTTGTCC
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USA), except for PCA analysis which was performed in 




The SPI1-lon-fliC mutant of S. Enteritidis and SPI1-lon-
fliC-fljB mutant of S. Infantis grew in the form of mucoid 
colonies. This mucoid phenotype was not observed in 
the SPI1-lon-fliC-fljB mutant of S. Typhimurium. Full 
genome sequencing confirmed the presence of all muta-
tions as designed and the absence of any additional dif-
ference between the wild type strain and appropriate 
mutant. Full genome sequencing also showed that both 
the wild type and mutant S. Typhimurium contained a 
3281 bp deletion flanked by 10 bp AATGCGCTGG direct 
repeat. This deletion comprised a 3′ end of the yojN gene, 
whole rcsB and a 5′ end of the rcsC gene explaining the 
absence of the mucoid phenotype in S. Typhimurium 
despite the lon gene deletion [27].
Protection against homologous challenge
When 6 chickens were examined for the presence of the 
vaccine strains on day 21, i.e. just before challenge, all 6 
chickens were positive for Salmonella in the cecum and 4 
out of 6 chickens were positive also in the liver. Out of 56 
randomly picked colonies, 2 belonged to serovar Enter-
itidis, 11 to Typhimurium and 43 to serovar Infantis.
When the chickens were challenged with wild type 
Salmonella Enteritidis, Typhimurium and Infantis, all 
chickens were positive in the cecum and since we expe-
rienced overgrowth of nalidixic acid microbiota, exact 
quantification was not possible. However, numerically 
lower Salmonella counts were always observed in the 
liver of vaccinated chickens, both 4 and 14  dpi. Due to 
having only six chickens per group, individual variation 
among chickens and the low virulence of the wild type S. 
Infantis, the protective effect was statistically significant 
only after challenge with the most virulent S. Enteritidis 
(Figure 1).
Protection against heterologous challenge
When 12 chickens were examined for the presence of 
the vaccine strains on day 21, i.e. just before challenge, 
all 12 chickens were positive for Salmonella in the 
cecum and 7 out of 12 chickens were positive also in the 
liver. Out of 88 randomly picked colonies, 1 belonged to 
serovar Enteritidis, 50 to Typhimurium and 37 to sero-
var Infantis.
When the vaccinated chickens were challenged with 
wild type S. Agona, S. Dublin, S. Hadar and S. Enteritidis 
as a control, the vaccination did not affect S. Enteritidis 
and S. Agona presence in the cecum. However, vaccina-
tion decreased S. Dublin cecum colonization and nearly 
completely protected chickens against S. Hadar infec-
tion (Table  2). The higher number of S. Dublin posi-
tive chickens in the group of vaccinated birds than in 
the non-vaccinated chickens at 4  dpi likely represented 
only random variation among low level colonized birds 
(Table 2). Liver colonization by S. Agona, S. Dublin and 
S. Hadar was quite low even in the non-vaccinated chick-
ens and no significant differences between the vaccinated 
and non-vaccinated chickens were recorded (Figure  2). 
As in the previous experiment (Figure 1), the vaccination 















































Figure 1 Protective effect of S. Enteritidis–Typhimurium–Infantis vaccine against challenge with homologous serovars. NV: non‑vac‑
cinated chickens, V: vaccinated chickens, SE, STM and SI: challenge with S. Enteritidis, Typhimurium or Infantis, respectively. Left panel, log CFU/g of 
liver 4 dpi; right panel, log CFU/g of liver 14 dpi. * significantly different from the appropriate non‑vaccinated control group by t test at P < 0.05.
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Long term shedding of vaccine strains
Since we recorded that the vaccine strains were present 
in the vaccinated chickens even on day 21 of life, in the 
next experiment we determined fecal shedding of the 
vaccination strains. Six chickens were vaccinated on day 
1 of life and revaccinated on day 21. Five or six out of six 
chickens were positive for Salmonella in cloacal swabs 
on weeks 6, 7 and 8 of life. A decrease in positivity was 
detected between weeks 9 and 11, and from week 11, all 
the chickens were Salmonella negative (Figure 3). Three 
individual isolates from three different chickens picked 
up on week 9 were confirmed by PCR to contain the SPI1 
deletion, i.e. to be one of three possible serovars present 
in the vaccine. Serological testing showed that all these 
isolates belonged to serovar Infantis.
Vaccination schemes and long term protection
In the last experiment we tested the long term protec-
tiveness of the vaccine in three different vaccination 
regimes. Unlike previous experiments, the chickens 
were challenged with S. Enteritidis only, but both orally 
and intravenously, and inflammation in the cecum was 
determined to better characterize the immune response. 
The characterization of cecal inflammation also partially 
substituted for missing quantitative data on Salmonella 
in the cecum.
Although quantitative determination of S. Enteritidis in 
the cecum was difficult due to an overgrowth of nalidixic 
acid resistant microbiota, all the chickens, irrespective of 
age or mode of challenge, were positive for Salmonella in 
the cecum 4 dpi.
Quantitative detection of S. Enteritidis in the liver 
showed that there were no differences between the 
response of 6 and 18-week chickens and we therefore 
combined data from these two age categories. Follow-
ing the challenge, orally vaccinated and orally challenged 
chickens were free of S. Enteritidis in the liver (Figure 4). 
Despite this, comparison with S. Enteritidis counts in 
Table 2 Number of Salmonella positive chickens in the 
ceca of vaccinated and non-vaccinated chickens following 
S. Agona, S. Dublin, S. Hadar and S. Enteritidis challenge
a Number of Salmonella positive chickens/number of tested chickens.
# Significantly different from the appropriate non-vaccinated control by χ2 test 
with P < 0.05.
Non‑Vacc. Vaccinated Non‑Vacc. Vaccinated
Challenge 4 dpi 14 dpi
 Enteritidis 6/6a 6/6 6/6 5/6
 Agona 6/6 6/6 6/6 6/6
 Dublin 3/6 5/6 6/6 2/6
 Hadar 4/6 1/6 6/6 0/6#
Figure 2 Protective effect of S. Enteritidis–Typhimurium–Infantis vaccine against challenge with heterologous serovars. NV: non‑
vaccinated chickens, V: vaccinated chickens, SE, SA, SD and SH: challenge with S. Enteritidis, Agona, Dublin and Hadar, respectively. Left panel, log 
CFU/g of liver 4 dpi; right panel, log CFU/g of liver 14 dpi. * significantly different from the appropriate non‑vaccinated control group by t test at 
P < 0.05.
Figure 3 Shedding of the vaccine strains by chickens as 
determined by cloacal swabbing. The chickens were vaccinated 
on day 1, revaccinated on day 21 of life and Salmonella presence in 
cloacal swabs was detected until four consecutive negative tests 
were recorded.
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the liver of non-vaccinated or aerosol vaccinated chick-
ens did not meet statistical significance (non-vacc vs. 
oral, P = 0.072, aerosol vs. oral, P = 0.076). Vaccination 
together with administration of cecal microbiota numeri-
cally reduced the efficacy of the vaccine but this differ-
ence did not reach statistical significance.
When the chickens were challenged intravenously, 
the best protection was observed in the chickens which 
were vaccinated by aerosol (Figure  4). Aerosol vacci-
nated chickens were significantly better protected against 
intravenous challenge than non-vaccinated or orally vac-
cinated chickens. Chickens vaccinated orally with cecal 
microbiota exhibited intermediate protection against 
intravenous challenge and the comparison of this group 
of chicken with non-vaccinated control approached 
statistical significance (non-vacc vs. oral  +  probio, 
P = 0.095).
Finally we determined the inflammatory response 
in the cecum of orally challenged chickens and in the 
liver of intravenously challenged chickens. The inflam-
matory response was determined by the expression of 
16 genes in the cecal tissue and 13 genes in the liver 
selected according to our previous reports [28, 29]. 
Expression of these genes was used only as a marker 
of inflammatory response expecting an increased 
response of naive animals to challenge with the wild 
type S. Enteritidis and lower or no response of vacci-
nated and challenged, or control chickens, respectively. 
We therefore did not consider biological function of 
these genes in this study. An increased inflammatory 
response in the cecum following oral challenge, similar 
to that in the non-vaccinated chickens but challenged 
chickens was observed in the chickens vaccinated via 
aerosol indicating quite low protection (Figure  5). On 
the other hand, effective protection characterized by 
a low inflammatory response, similar to that observed 
in the non-vaccinated and non-infected chickens, was 
observed in orally vaccinated groups of chickens. Due 
to the repeatedly lower inflammatory response to the 
challenge in the cecum of chickens administered the 
vaccine together with cecal microbiota in comparison 
with the chickens vaccinated without cecal microbiota, 
we concluded that such chickens were slightly better 
protected than the chickens vaccinated with the vac-
cine only (Figure 5).
Gene expression in the liver after intravenous infec-
tion supported the results from bacteriology shown in 
Figure  4. A high inflammatory response to the chal-
lenge was observed in the non-vaccinated chickens (Fig-
ure 6). On the other hand, the most efficient protection 
characterized by a low inflammatory response charac-
teristic of resistant chickens was observed in aerosol-
vaccinated chickens. Unlike oral challenge, intravenous 
challenge resulted in repeatedly slightly higher inflamma-
tory response in the liver of chickens given the vaccine 
together with cecal microbiota in comparison with the 
chickens vaccinated orally without cecal microbiota. This 
indicated that the cecal microbiota provided together 
with vaccine negatively affected development of systemic 
immunity (Figure 6).
Discussion
In this study we compared the vaccine potential of S. 
Enteritidis, S. Typhimurium and S. Infantis SPI1, lon and 
flagella mutants in homologous and heterologous chal-
lenge models in chickens. In addition, we also compared 
aerosol and oral vaccine administration, and in the case 
of oral vaccination, we tested its administration together 
with cecal microbiota of adult hens.
Vaccine strains persisted in the chickens until approx. 
week 10 of life, the time at which also wild type Salmo-
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*
#
Figure 4 S. Enteritidis counts in individual chickens after oral or intravenous challenge. Left panel, S. Enteritidis counts in the liver 4 days 
following oral challenge. “w” indicates age of individual chickens at the time of infection. Right panel, S. Enteritidis counts in the liver 4 days follow‑
ing intravenous challenge. * significantly different from non‑vaccinated chickens, # significantly different from orally vaccinated chicken by ANOVA 
at P < 0.05.
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the non-invasive hilA mutant of S. Enteritidis, function-
ally similar to the SPI1 mutation used in the attenuated 
strains in this study, was reported to be shed for 4 weeks 
only [30]. This was probably caused by the presence of 
the S. Infantis strain in the vaccine, which persisted in 
the inoculated chickens the longest. However, when we 
used the parental S. Infantis strain for challenge, this 
strain was the least virulent, which was consistent with 
an earlier report on the virulence of S. enterica for chick-
ens where S. Enteritidis was the most virulent, followed 
by S. Typhimurium, and lastly S. Infantis [31]. Despite 
the lower recovery of the S. Enteritidis vaccine strain, the 
vaccination protected against challenge with all serovars 
present in the vaccine. The vaccine exhibited a protec-
tive effect also towards S. Hadar and partial protection 
against S. Dublin. S. Enteritidis, S. Typhimurium and 
S. Infantis vaccine did not protect chickens against S. 
Agona. This was a little bit surprising since we expected 
cross-protection between S. Agona and S. Dublin due to 
the presence of the common O-antigen in S. Agona and 
S. Typhimurium, and in S. Dublin and S. Enteritidis. Our 
results therefore showed that vaccination with S. Enter-
itidis, S. Typhimurium and S. Infantis vaccine exhibited a 
certain degree of cross-protection against strains belong-
ing to heterologous serovars but such protection was 
dependent not only on serovar classification but also on 
the overall genetic composition of each individual iso-
late. However, we have to remind that the differences 
following the challenge with heterologous serovars were 
quite low, both due to the increasing resistance of chick-
ens to Salmonella infection with increasing age [32] and 
reduced virulence of non-S. Enteritidis serovars for chick-
ens [31] and additional experiments will have to be per-
formed to finally confirm or dispute these observations.
Aerosol vaccination is an efficient alternative to oral 
vaccination [10–12]. Another alternative increasing the 
vaccine’s potential is the administration of a live Sal-
monella vaccine together with probiotics or competi-
tive exclusion products [16]. Both Salmonella counts 
and the inflammatory response confirmed that aerosol 
Figure 5 Gene expression in the chicken in cecal tissue following vaccination and oral challenge. Upper panel, Principal Component 
Analysis (PCA) of individual chickens using “integrated” expression of 16 genes used for the characterization of chicken response to S. Enteritidis 
challenge. The chickens vaccinated by aerosol responded to the infection similarly as the non‑vaccinated chickens indicating the lowest protection. 
On the other hand, orally vaccinated chickens clustered with the non‑infected controls showing the highest protective effect of oral vaccination. 
Con: control, non‑vaccinated and non‑infected chickens, Inf: non‑vaccinated but infected chickens, Or: orally vaccinated and infected chickens, 
OrP: orally vaccinated together with administration of cecal microbiota (probiotics) and infected chickens, Aer: aerosol vaccinated and infected 
chickens. Lower row of four panels, average expression of four genes with the highest expression in the chicken cecum following oral infection with 
S. Enteritidis. AVD: avidin, ExFABP: extracellular fatty acid binding protein, SAA: serum amyloid A, ES1: ES1 protein homolog, mitochondrial‑like. For 
the expression of all individual genes, see Additional file 1. * significantly different from non‑vaccinated chickens but infected chickens by ANOVA at 
P < 0.05.
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vaccination induced a greater systemic immune response. 
However, unlike in previous studies [10–12], the aerosol 
vaccination was less protective in the cecum than the 
oral vaccination. It is likely that multiple sites including 
the digestive tract, respiratory tract or conjunctiva are 
stimulated during aerosol vaccination which results in 
a systemic immune response. On the other hand, oral 
administration of the vaccine resulted mainly in a local-
ized stimulation of the intestinal tract. These results were 
confirmed both by Salmonella counting and by determi-
nation of inflammatory response. Based on our previous 
reports we assumed that lower response after challenge 
with wild type Salmonella corresponded with higher pro-
tection [7, 27–29]. The response of individual chickens 
was similar for different gene categories like chemokine 
and cytokines (CSF3, AH221, SCYA4, IL-22, IL8, INFγ), 
acute phase proteins (ExFABP, MRP126, SAA, TRAP6) 
or proteins and enzymes with effector functions (IL4I1, 
iNOS, LYG2, IgG, PTGDS). Since the acute phase 
proteins are usually expressed at higher levels than 
cytokines and therefore provide more reliable results fol-
lowing real time PCR, we highlighted them in Figures 5 
and 6.
Co-administration of cecal microbiota from adult 
healthy hens together with the vaccine did not improve 
vaccine efficacy in terms of reduced Salmonella counts 
in the liver, but slightly decreased inflammatory signal-
ing in the cecum following oral challenge. Administration 
of microbiota and the vaccine resulted also in a lower 
systemic protection since higher Salmonella counts and 
higher inflammatory response were observed follow-
ing intravenous challenge. The co-administration of the 
vaccine and microbiota might lead to decreased antigen 
recognition and development of a systemic and specific 
immune response. On the other hand, administration 
of healthy microbiota decreased inflammatory respon-
siveness after oral challenge though it will have to be 
tested whether a single microbiota administration on day 
Figure 6 Gene expression in the chicken liver following vaccination and intravenous challenge. Upper panel, Principal Component 
Analysis (PCA) of individual chickens using “integrated” expression of 13 genes used for the characterization of chicken response to S. Enteritidis 
challenge. The chickens vaccinated with the vaccine mixed with probiotics responded to the infection similarly as the non‑vaccinated chickens 
indicating their lowest level of protection. On the other hand, aerosol vaccinated chickens clustered the closest to the non‑infected controls indicat‑
ing the highest level of protection against intravenous challenge. Con: control, non‑vaccinated and non‑infected chickens, Inf: non‑vaccinated but 
infected chickens, Or: orally vaccinated and infected chickens, OrP: orally vaccinated together with administration of cecal microbiota (probiotics) 
and infected chickens, Aer: aerosol vaccinated and infected chickens. Lower row of four panels, average expression of four genes with the highest 
expression in the chicken cecum following oral infection with S. Enteritidis. AVD: avidin, ExFABP: extracellular fatty acid binding protein, SAA: serum 
amyloid A, PTGDS: Prostaglandin D2 synthase. For the expression of all individual genes, see Additional file 1. * significantly different from non‑vacci‑
nated chickens but infected chickens by ANOVA at P < 0.05.
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1 of life may affect inflammatory signaling at 6 or even 
18  weeks of age. Despite this, co-administration of a 
live Salmonella vaccine together with undefined micro-
biota presents an interesting topic for future investiga-
tions, although we have to admit that the differences in 
the gene expression in the cecum were quite low, likely 
due to know increase in general resistance of chickens to 
colonization with S. Enteritidis or S. Typhimurium with 
increasing age [8, 32].
We have shown that a vaccine consisting of attenuated 
S. Enteritidis, S. Typhimurium and S. Infantis strains pro-
tects chickens against challenge with the wild type strains 
of the same serovars and may protect also against iso-
lates belonging to other serovars such as Dublin or Hadar 
although protection against heterologous serovars may 
depend on the particular genetic composition of each 
field isolate. Aerosol vaccine administration is an inter-
esting alternative to oral vaccination. However, care must 
be taken on the site of expected maximal immune protec-
tion. In addition, aerosol administration in particular may 
raise question on the vaccine safety to human personnel, 
an issue which we did not address in this study. Finally, an 
additional co-administration of microbiota from healthy 
adult hens together with the vaccine may (i) protect the 
chickens immediately after administration, (ii) induce 
a specific immune response following the vaccination, 
and (iii) even decrease the inflammatory responsive-
ness of adult hens. Administration of gut microbiota of 
appropriate composition may protect young chicken on 
its own, without induction of specific anti-Salmonella 
immune response, however, this may represent an issue 
in egg laying hens during egg laying period.
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